To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
doi: 10.1001/jamasurg.2024.0111
Together, these hormones are known as incretins
Studies show people usually regain weight [archived link] after stopping GLP-1 RAs
They found that fat cells near the tumor can make the cancer cells resistant to treatment
Persistent Itching Itching, or pruritus, is perhaps the most distracting symptom